https://www.selleckchem.com/pr....oducts/nvp-tnks656.h
s needed to understand the barriers to increase the compliance with recommendations along with targeted educational campaigns in low-compliance populations. Early administration of tranexamic acid (TXA) has been widely implemented for the treatment of presumed hyperfibrinolysis in hemorrhagic shock. We aimed to characterize the liberal use of TXA and whether unjustified administration was associated with increased venous thrombotic events (VTEs). We identified injured patients who received TXA between January 2016 and January 2018 b
Like
Comment
Share
